Paper
18 February 2014 Combination of nitric oxide therapy, anti-oxidative therapy, low level laser therapy, plasma rich platelet therapy and stem cell therapy as a novel therapeutic application to manage the pain and treat many clinical conditions
Salaheldin Halasa, Eva Dickinson
Author Affiliations +
Proceedings Volume 8932, Mechanisms for Low-Light Therapy IX; 893205 (2014) https://doi.org/10.1117/12.2038329
Event: SPIE BiOS, 2014, San Francisco, California, United States
Abstract
From hypertension to diabetes, cancer to HIV, stroke to memory loss and learning disorders to septic shock, male impotence to tuberculosis, there is probably no pathological condition where nitric oxide does not play an important role. Nitric oxide is an analgesic, immune-modulator, vasodilator, anti-apoptotic, growth modulator, angiogenetic, anti-thrombotic, anti-inflammatory and neuro-modulator. Because of the above actions of nitric oxide, many clinical conditions associated with abnormal Nitric oxide (NO) production and bioavailability. Our novel therapeutic approach is to restore the homeostasis of nitric oxide and replace the lost cells by combining nitric oxide therapy, anti-oxidative therapy, low level laser therapy, plasma rich platelet therapy and stem cell therapy.
© (2014) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Salaheldin Halasa and Eva Dickinson "Combination of nitric oxide therapy, anti-oxidative therapy, low level laser therapy, plasma rich platelet therapy and stem cell therapy as a novel therapeutic application to manage the pain and treat many clinical conditions", Proc. SPIE 8932, Mechanisms for Low-Light Therapy IX, 893205 (18 February 2014); https://doi.org/10.1117/12.2038329
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
NOx

Laser therapeutics

Stem cells

Plasma

Cancer

Bone

Tissues

Back to Top